Cargando…
Evidence supports blind screening for internal malignancy in dermatomyositis: Data from 2 large US dermatology cohorts
The association between dermatomyositis and internal malignancy is well established, but there is little consensus about the methods of cancer screening that should be utilized. We wished to analyze the prevalence and yield of selected cancer screening modalities in patients with dermatomyositis. We...
Autores principales: | Leatham, Hayley, Schadt, Courtney, Chisolm, Sarah, Fretwell, Deborah, Chung, Lorinda, Callen, Jeffrey P., Fiorentino, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5943873/ https://www.ncbi.nlm.nih.gov/pubmed/29480875 http://dx.doi.org/10.1097/MD.0000000000009639 |
Ejemplares similares
-
Clinical Presentation and Evaluation of Dermatomyositis
por: Marvi, Umaima, et al.
Publicado: (2012) -
Atherosclerotic cardiovascular disease and dermatomyositis: an analysis of the Nationwide Inpatient Sample survey
por: Linos, Eleni, et al.
Publicado: (2013) -
Immune responses to CCAR1 and other dermatomyositis autoantigens are associated with attenuated cancer emergence
por: Fiorentino, David F., et al.
Publicado: (2022) -
Dermatomyositis and malignancy: should all patients with dermatomyositis undergo malignancy screening?
por: Khanna, Urmi, et al.
Publicado: (2021) -
Importance of collaboration of dermatology and rheumatology to advance the field for lupus and dermatomyositis
por: Werth, Victoria P., et al.
Publicado: (2021)